{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:05:26Z","timestamp":1773273926596,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,7,27]],"date-time":"2008-07-27T00:00:00Z","timestamp":1217116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00213-008-1218-4","type":"journal-article","created":{"date-parts":[[2008,7,26]],"date-time":"2008-07-26T09:33:14Z","timestamp":1217064794000},"page":"439-450","source":"Crossref","is-referenced-by-count":119,"title":["Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (\u00b1)3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) users: relationship to cognitive performance"],"prefix":"10.1007","volume":"200","author":[{"given":"Una D.","family":"McCann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melin","family":"Vranesic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayden T.","family":"Ravert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Dannals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Ricaurte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,27]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00221309.1948.9918159","volume":"39","author":"EA Berg","year":"1948","unstructured":"Berg EA (1948) A simple objective technique for measuring flexibility in thinking. J Gen Psych 39:15\u201322","journal-title":"J Gen Psych"},{"key":"1218_CR2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S0033291701003828","volume":"31","author":"S Bhattachary","year":"2001","unstructured":"Bhattachary S, Powell JH (2001) Recreational use of 3,4 methylenedioxymethamphetamine (MDMA) or \u2018ecstasy\u2019: evidence for cognitive impairment. Psychol Med 31:647\u2013658","journal-title":"Psychol Med"},{"key":"1218_CR3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1212\/WNL.51.6.1532","volume":"51","author":"KI Bolla","year":"1998","unstructured":"Bolla KI, McCann UD, Ricaurte GA (1998) Impaired memory function in abstinent MDMA (\u201cecstasy\u201d) users. Neurology 51:1532\u20131537","journal-title":"Neurology"},{"key":"1218_CR4","first-page":"375","volume":"44","author":"R Buchert","year":"2003","unstructured":"Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M (2003) Long-term effects of \u201cecstasy\u201d use on serotonin transporters of the brain investigated by PET. J Nucl Med 44:375\u2013384","journal-title":"J Nucl Med"},{"key":"1218_CR5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1176\/appi.ajp.161.7.1181","volume":"161","author":"R Buchert","year":"2004","unstructured":"Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M (2004) A voxel-based PET investigation of the long-term effects of \u201cecstasy\u201d consumption on brain serotonin transporters. Am J Psychiatry 161:1181\u20131189","journal-title":"Am J Psychiatry"},{"key":"1218_CR6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0006-2952(95)02397-6","volume":"51","author":"T Chu","year":"1996","unstructured":"Chu T, Kumagai Y, DiStefano EW, Cho AK (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51:789\u2013796","journal-title":"Biochem Pharmacol"},{"key":"1218_CR7","first-page":"338","volume":"241","author":"DL Commins","year":"1987","unstructured":"Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338\u2013345","journal-title":"J Pharmacol Exp Ther"},{"key":"1218_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-003-1561-4","volume":"173","author":"RI Dafters","year":"2004","unstructured":"Dafters RI, Hoshi R, Talbot AC (2004) Contribution of cannabis and MDMA (\u201cecstasy\u201d) to cognitive changes in long-term polydrug users. Psychopharmacology (Berl) 173:405\u2013410","journal-title":"Psychopharmacology (Berl)"},{"key":"1218_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jlcr.2580330209","volume":"33","author":"R Dannals","year":"1993","unstructured":"Dannals R, Neumeyer J, Milius R, Ravert H, Wilson A, Wagner H (1993) Synthesis of a radiotracer for studying dopamine uptake sites in vivo using PET: 2b-carbomethoxy-3b-(4-fluorophenyl)-[N-11C-methyl]tropane ([11C]WIN-35,428). J Label Compd Radiopharm 33:147\u2013153","journal-title":"J Label Compd Radiopharm"},{"key":"1218_CR10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","volume":"49","author":"R Torre de la","year":"2000","unstructured":"de la Torre R, Farre M, Ortuno J, Mas M, Brenneisen R, Roset PN, Segura J, Cami J (2000) Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans. Br J Clin Pharmacol 49:104\u2013109","journal-title":"Br J Clin Pharmacol"},{"key":"1218_CR11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0269881106061153","volume":"20","author":"N Easton","year":"2006","unstructured":"Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20:194\u2013210","journal-title":"J Psychopharmacol"},{"key":"1218_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10401230601163592","volume":"19","author":"RS El-Mallakh","year":"2007","unstructured":"El-Mallakh RS, Abraham HD (2007) MDMA (ecstasy). Ann Clin Psychiatry 19:45\u201352","journal-title":"Ann Clin Psychiatry"},{"key":"1218_CR13","volume-title":"Structured clinical interview for DSM-IV axis I disorders (SCID-I), clinician version","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB (1997) Structured clinical interview for DSM-IV axis I disorders (SCID-I), clinician version. American Psychiatric, Arlington, VA"},{"key":"1218_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hup.344","volume":"16","author":"HC Fox","year":"2001","unstructured":"Fox HC, Toplis AS, Turner JJD, Parrott AC (2001) Auditory verbal learning in drug-free ecstasy polydrug users. Hum Psychopharmacol 16:613\u2013618","journal-title":"Hum Psychopharmacol"},{"key":"1218_CR15","first-page":"815","volume":"47","author":"WG Frankle","year":"2006","unstructured":"Frankle WG, Slifstein M, Gunn RN, Huang Y, Hwang DR, Darr EA, Narendran R, Abi-Dargham A, Laruelle M (2006) Estimation of serotonin transporter parameters with 11C-DASB in healthy humans reproducibility and comparison of methods. J Nucl Med 47:815\u2013826","journal-title":"J Nucl Med"},{"key":"1218_CR16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.68.6.719","volume":"68","author":"E Gouzoulis-Mayfrank","year":"2000","unstructured":"Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert H, Fimm B, Sass H (2000) Impaired cognitive impairment in drug free users of recreational ecstasy. J Neurol Neurosurg Psychiatry 68:719\u2013725","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1218_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Rev 55:463\u2013508","journal-title":"Pharmacol Rev"},{"key":"1218_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1192\/bjp.176.2.193-a","volume":"176","author":"A Heinz","year":"2000","unstructured":"Heinz A, Jones DW (2000) Serotonin transporters in ecstasy users. Br J Psychiatry 176:193\u2013195","journal-title":"Br J Psychiatry"},{"key":"1218_CR19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cerebr Blood Flow Metab 27:1533\u20131539","journal-title":"J Cerebr Blood Flow Metab"},{"key":"1218_CR20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-006-0601-2","volume":"189","author":"AD Kalechstein","year":"2007","unstructured":"Kalechstein AD, De La Garza R 2nd, Mahoney JJ 3rd, Fantegrossi WE, Newton TF (2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology 189:531\u2013537","journal-title":"Psychopharmacology"},{"key":"1218_CR21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","volume":"60","author":"L Kerenyi","year":"2003","unstructured":"Kerenyi L, Ricaurte GA, Schretlen DJ, McCann U, Varga J, Mathews WB, Ravert HT, Dannals RF, Hilton J, Wong DF, Szabo Z (2003) Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol 60:1223\u20131229","journal-title":"Arch Neurol"},{"key":"1218_CR22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0269881106059495","volume":"20","author":"CT Lamers","year":"2006","unstructured":"Lamers CT, Bechara A, Rizzo M, Ramaekers JG (2006) Cognitive function and mood in MDMA\/THC users, THC users and non-drug using controls. J Psychopharmacol 20:302\u2013311","journal-title":"J Psychopharmacol"},{"key":"1218_CR23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0969-8051(00)00142-6","volume":"27","author":"M Laruelle","year":"2000","unstructured":"Laruelle M (2000) The role of model-based methods in the development of single scan techniques. Nucl Med Biol 27:637\u2013642","journal-title":"Nucl Med Biol"},{"key":"1218_CR24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/syn.890130402","volume":"13","author":"M Laruelle","year":"1993","unstructured":"Laruelle M, Baldwin RM, Mallison RT, Zea Ponce Y, Zoghbi SS, Al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL, Milius RA, Wan S, Smith EO, Roth RH, Charney DS, Hoffer PB, Innis RB (1993) SPECT imaging of dopamine and serotonin transporters with 123I beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295\u2013309","journal-title":"Synapse"},{"key":"1218_CR25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1137\/0111030","volume":"11","author":"DW Marquardt","year":"1963","unstructured":"Marquardt DW (1963) An algorithm for least-squares estimation of non-linear parameters. J Soc Ind Appl Math 11:431\u2013441","journal-title":"J Soc Ind Appl Math"},{"key":"1218_CR26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(98)04329-3","volume":"352","author":"UD McCann","year":"1998","unstructured":"McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA (\u201cecstasy\u201d) on brain serotonin neurons in human beings. Lancet 352:1433\u20131437","journal-title":"Lancet"},{"key":"1218_CR27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpsyc.58.10.907","volume":"58","author":"UD McCann","year":"2001","unstructured":"McCann UD, Ricaurte GA, Molliver ME (2001) \u201cEcstasy\u201d and serotonin neurotoxicity: new findings raise more questions. Arch Gen Psychiatry 58:907\u2013908","journal-title":"Arch Gen Psychiatry"},{"key":"1218_CR28","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.npp.1300736","volume":"30","author":"UD McCann","year":"2005","unstructured":"McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2005) Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 30:1741\u20131750","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"1218_CR29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.npp.1301302","volume":"32","author":"UD McCann","year":"2007","unstructured":"McCann UD, Peterson SC, Ricaurte GA (2007) The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology 32(8):1695\u2013706","journal-title":"Neuropsychopharmacology"},{"key":"1218_CR30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300808","volume":"31","author":"A Mechan","year":"2006","unstructured":"Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA (2006) Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology 31:339\u2013350","journal-title":"Neuropsychopharmacology"},{"key":"1218_CR31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s002130100907","volume":"159","author":"MJ Morgan","year":"2002","unstructured":"Morgan MJ, McFie L, Fleetwood LH, Robinson J (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294\u2013303","journal-title":"Psychopharmacology"},{"key":"1218_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881105048900","volume":"19","author":"AC Parrott","year":"2005","unstructured":"Parrott AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J Psychopharmacol 19:71\u201383","journal-title":"J Psychopharmacol"},{"key":"1218_CR33","volume-title":"The Halstead\u2013Reitan neuropsychological test battery: theory and clinical interpretation","author":"RM Reitan","year":"1993","unstructured":"Reitan RM, Wolfson D (1993) The Halstead\u2013Reitan neuropsychological test battery: theory and clinical interpretation. Neuropsychology, Tucson, AZ"},{"key":"1218_CR34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s002130050057","volume":"148","author":"L Reneman","year":"2000","unstructured":"Reneman L, Booij J, Schmand B, van den Brink W, Gunning B (2000) Memory disturbances in \u201cecstasy\u201d users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148:322\u2013324","journal-title":"Psychopharmacology"},{"key":"1218_CR35","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archpsyc.58.10.901","volume":"58","author":"L Reneman","year":"2001","unstructured":"Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d): preliminary findings. Arch Gen Psychiatry 58:901\u2013906","journal-title":"Arch Gen Psychiatry"},{"key":"1218_CR36","volume-title":"L\u2019examen clinicque en psychologie","author":"A Rey","year":"1964","unstructured":"Rey A (1964) L\u2019examen clinicque en psychologie. Presses Universitaires de France, Paris"},{"issue":"6","key":"1218_CR37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archpsyc.64.6.728","volume":"64","author":"T Schilt","year":"2007","unstructured":"Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B (2007) Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry 64(6):728\u2013736","journal-title":"Arch Gen Psychiatry"},{"key":"1218_CR38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.175.1.63","volume":"175","author":"DM Semple","year":"1999","unstructured":"Semple DM, Ebmeier KP, Glabus MF, O\u2019Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (\u2018ecstasy\u2019) users. Br J Psychiatry 175:63\u201369","journal-title":"Br J Psychiatry"},{"issue":"5","key":"1218_CR39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1360-0443.1994.tb03330.x","volume":"89","author":"TD Steele","year":"1994","unstructured":"Steele TD, McCann UD, Ricaurte GA (1994) 3,4-Methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d): pharmacology and toxicology in animals and humans. Addiction 89(5):539\u2013551","journal-title":"Addiction"},{"key":"1218_CR40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643\u2013661","journal-title":"J Exp Psychol"},{"key":"1218_CR41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00004647-199909000-00004","volume":"19","author":"Z Szabo","year":"1999","unstructured":"Szabo Z, Scheffel U, Mathews WB, Ravert HT, Szabo K, Kraut M, Palmon S, Ricaurte GA, Dannals RF (1999) Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand. J Cereb Blood Flow Metab 19:967\u2013981","journal-title":"J Cereb Blood Flow Metab"},{"key":"1218_CR42","first-page":"678","volume":"43","author":"Z Szabo","year":"2002","unstructured":"Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA (2002) Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med 43:678\u2013692","journal-title":"J Nucl Med"},{"key":"1218_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-002-1383-9","volume":"167","author":"R Thomasius","year":"2003","unstructured":"Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 167:85\u201396","journal-title":"Psychopharmacology (Berl)"},{"key":"1218_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269881106059486","volume":"20","author":"R Thomasius","year":"2006","unstructured":"Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 20:211\u2013225","journal-title":"J Psychopharmacol"},{"key":"1218_CR45","volume-title":"Wechsler memory scale-revised: manual","author":"D Wechsler","year":"1987","unstructured":"Wechsler D (1987) Wechsler memory scale-revised: manual. Psychological, New York, NY"},{"key":"1218_CR46","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/jm000079i","volume":"43","author":"AA Wilson","year":"2000","unstructured":"Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S (2000) Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. J Med Chem 43:3103\u20133110","journal-title":"J Med Chem"},{"key":"1218_CR47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.0022-3042.2002.00758.x","volume":"80","author":"J Yuan","year":"2002","unstructured":"Yuan J, Cord BJ, McCann UD, Callahan BT, Ricaurte GA (2002) Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity. J Neurochem 80:960\u2013969","journal-title":"J Neurochem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1218-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:06:42Z","timestamp":1558642002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,27]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1218-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,27]]}}}